CaV3.1 channels have been proposed as potential therapeutic targets for the prevention and treatment of obesity (Uebele et al., 2009; Vasconcelos et al., 2016; Chidrawar and Ali, 2020; Zhai et al., 2020). This evidence concerns the gene CACNA1G and obesity due to melanocortin 4 receptor deficiency.